Director/PDMR Shareholding

RNS Number : 2045W

Deltex Medical Group PLC

23 January 2013

 



 

 

Deltex Medical Group plc

Completion of Placing and Directors shareholdings

23 January 2013 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that the 13,157,895 new ordinary shares issued as part of the Placing announced on 18 January 2013 have now been admitted for trading.

As part of the arrangements for the Placing, three Non-executive Directors subscribed for approximately £225,000 in the Placing, representing 9% of the issue. These Directors' beneficial interests are now as follows:

Name of Director	Number of New Ordinary Shares subscribed as part of Placing	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Nigel Keen	789,000	6,687,547	4.1
Sir Duncan Nichol	131,500	853,916	0.5
Julian Cazalet	263,000	3,880,882	2.4

The Company has 164,190,150 ordinary shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Deltex Medical Group plc, under the Disclosure and Transparency Rules.

For further information, please contact:-

Deltex Medical Group plc                                                                                01243 774 837
Nigel Keen, Chairman                                        
Ewan Phillips, Chief Executive                           
Paul Mitchell, Finance Director               

Nominated Adviser and Broker                                                                        0207 614 5917

Arden Partners plc 

Christopher Hardie

 

END

 

 

RDSLLFVFLRIVFIV